Skip to content
Back to the product range

PX1 / 10 mg

TB-500

A research peptide associated with the thymosin beta-4 research field.

10 mgRecovery

For research use only. Not intended for human use.

The research information on this page describes published studies about the molecule and does not demonstrate the effect, safety, purity, or quality of PX1Labs' research material.

PX1 TB-500 10 mg

01

What is it?

10 mg

TB-500 is a name used for a synthetic research peptide, while published literature often centers on thymosin beta-4.

02

What is being studied?

  1. 01

    Cell migration and actin-related processes

  2. 02

    Tissue models and preclinical repair research

  3. 03

    Clear distinction between TB-500 and thymosin beta-4

Scientific overview

TB-500: molecule, research fields and evidence boundaries

TB-500 is a name used for a synthetic research peptide, while published literature often centers on thymosin beta-4. A research peptide associated with the thymosin beta-4 research field. The overview below separates mechanistic, preclinical and human evidence from properties of a specific PX1Labs vial.

What the literature examines

Evidence focus · Important boundary
Research field
01
Evidence focus
Cell migration and actin-related processes
Important boundary
A research-model result does not establish clinical effect or properties of a specific vial.
Research field
02
Evidence focus
Tissue models and preclinical repair research
Important boundary
A research-model result does not establish clinical effect or properties of a specific vial.
Research field
03
Evidence focus
Clear distinction between TB-500 and thymosin beta-4
Important boundary
A research-model result does not establish clinical effect or properties of a specific vial.

Profile highlights

investigational molecule status
Research peptide
amount stated on the vial
10 mg
clinical transferability depends on study type
Limited

Source and evidence map

Evidence type · Context · Inference limit
Source
Thymosin beta-4 research — PubMed
Evidence type
Published source
Context
The original source defines its methods and studied material.
Inference limit
Does not verify identity, purity or effect of a PX1Labs vial.

Evidence-level distinction

What it can show · Product link · Boundary
Level
Cell/laboratory model
What it can show
Mechanistic signal
Product link
Indirect
Boundary
Does not establish clinical effect
Level
Animal model
What it can show
Preclinical outcome
Product link
Indirect
Boundary
Not human evidence
Level
Human evidence
What it can show
Observation or clinical study
Product link
Molecule-specific
Boundary
Does not verify vial quality

Evidence levels are not interchangeable. A finding about a molecule does not establish the identity, purity or effect of a specific research material.

Scientific and regulatory boundary

TB-500 and thymosin beta-4 should not automatically be treated as identical. Findings for one material cannot be transferred to another without evidence.

03

What to keep in mind

TB-500 and thymosin beta-4 should not automatically be treated as identical. Findings for one material cannot be transferred to another without evidence.

Read the sources